On several occasions we have observed retrovirus-like particles (RVLPs) by transmission electron microscopy (EM) of cultured T cells from a patient with MS. Later we established spontaneously formed B-lymphoblastoid cell lines (LCLs) from a patient with an MS-like disease and from another patient with MS who had a reactivated Epstein-Barr virus (EBV) infection. Both LCLs were found by EM to produce RVLP and EBV particles. Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs. To substantiate these findings we initiated an intensified culturing procedure and were able to establish LCLs from 5 out of 21 consecutive MS patients and 1 out of 13 consecutive healthy controls. All LCLs were found to produce both RVLP and EBV particles by EM. Whether the putative new retrovirus(es) and EBV have any causal relationship to MS is still not known, but the findings support this possibility.
1 Martyn C. (1991) The epidemiology of multiple sclerosis. In: Matthews WB, (ed) McAlpine's Multiple Sclerosis2nd edn.Churchill Livingstone: Edinburgh, pp 3–40.
2.
2 Gessain A et al. (1985) Antibodies to HTLV-I in patients with tropical spastic paraparesis. Lancet2: 407–409.
3.
3 Haahr S et al. (1991) Just another dubious virus in cells from a patient with multiple sclerosis? Lancet1: 863–864.
4.
4 Sommerlund M et al. (1993) Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathy. Acta Neurol Scand87: 71–76.
5.
5 Haahr S et al. (1994) A putative new retrovirus associated with multiple sclerosis and the possible involvement of Epstein-Barr virus in this disease. Ann NY Acad Science724: 148–156.
6.
6 Schreiber SL, Craabtree GR. (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today13: 136–142.
7.
7 Wang F et al. (1990) Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3c are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol64: 2309–2318.
8.
8 Young LS et al. (1991) Differentiation-associated expression of the Epstein—Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol65: 2868–2874.
9.
9 Morling N, Hansen H. (1993) Paternity testing with VNTR DNA systems. I. Matching criteria and population frequencies of the VNTR systems D2S44, D5S43, D7S43, D7S21, D7S22, and D12S11 in Danes. Int J Leg Med106: 189–196.
10.
10 Hansen H, Morling N. (1993) Paternity testing with VNTR DNA systems. II. Evaluation of 271 cases of disputed paternity with the VNTR systems D2S44, D5S43, D7S21, D7S22, and D12S11. Int J Leg Med106: 197–202.
11.
11 Thyman M et al. (1993) Analysis of the locus D1S80 by amplified fragments length polymorphism technique (AMP-FLP). Frequency distribution in Danes. Intra and inter laboratory reproducibility of the technique. Forensic Sci Int60: 47–56.
12.
12 Nellemann L, Møller A, Morling N. (1994) PCR typing of DNA fragments of the short tandem repeat (STR) system HUMTH01 in Danes and Greenland Eskimos. Forensic Sci Int68: 45–51.
13.
13 Miller G. (1990) The switch between latency and replication of Epstein-Barr virus. J Inf Dis161: 833–844.
14.
14 Fraser KB, Haire M, Millar JHD, McCrea S. (1979) Increased tendency to spontaneous HI vitro lymphocyte transformation in clinically active multiple sclerosis. Lancet2: 715–717.
15.
15 Pattengale PK, Gerber P, Smith RW. (1973) Selective transformation of B lymphocytes by EB virus. Lancet2: 1153–1155.
16.
16 Nilsson K. (1979) The nature of lymphoid cell lines and their relationship to the virus. In: Epstein MA and Achong BGT (eds). The Epstein-Barr Virus.BerlinSpringer: pp 225–262.
17.
17 Yao QY, Rickinson AB, Epstein MA. (1985) A re-examination of the Epstein—Barr virus carrier state in healthy seropositive individuals. Int J Cancer35: 35–42.
18.
18 Kieff E, Liebowitz D. (1990) Epstein-Barr virus and its replication. In: Fields BN and Knipe DM (ed). Virology: 1889–1920.Raven Press: New York.
19.
19 Lai PK, Li X, Volsky DJ. (1989) Induction of Epstein-Barr virus in B-lymphoblastoid cells by human immunodeficiency virus type 1. Int J Cancer43: 1104–1111.
20.
20 Ohtsuki Y et al. (1990) Ribosome-lamella complexes observed in an Epstein—Barr virus-producing B-cell line, infected with human T-lymphotropic virus type I. J Pathol161: 191–194.
23 Sumaya CV, Myers LW, Ellison GW, Ench Y. (1985) Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol17: 371–377.
24.
24 Myrmel H, Nyland H. (1992) A case-control study of prevalence of antibodies against Epstein-Barr virus in multiple sclerosis patients in Hordaland Country, Norway. NIPS Annals1: 55.
25.
25 Haahr S et al. (1995) Increased risk of multiple sclerosis after late Epstein-Barr virus infection. Mult Scler Clin Lab Res1: 73–77.
26.
26 Haahr S et al. (1992) Multiple sclerosis is caused by a dual infection with retrovirus and Epstein-Barr virus? Neuroepidemiology11: 299–303.
